February 26, 2021
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus.
“Dr. Kousoulas is one of the world’s most eminent virologists. His work in the field of HSV gives hopes to the millions of patients who are in desperate need of a better standard of care and to all of us who work to defeat this heinous virus,” said Rational Vaccines CEO Agustin Fernandez. “No one understands this virus better than Gus. His addition to the team brings us one step closer to our goal of eradicating the Herpes pandemic.”
Dr. Konstantin Kousoulas is a professor of virology and biotechnology in the Louisiana State University Department of Pathobiological Sciences and director of the Division of Biotechnology and Molecular Medicine (BioMMED).
Dr. Konstantin Kousoulas research focuses primarily on the molecular biology and the immunopathogenesis of human herpes viruses. He has extensively utilized herpes simplex viral vectors for vaccine development and cancer treatment. He has also constructed and patented herpes simplex viruses that have been shown to be highly effective as preventative and therapeutic vaccines for herpes genital and ocular infections, as well as potent adjuvants for cancer immunotherapy, approaches in animal models.
Kousoulas’ work has been published in a variety of scientific publications including the Journals of Veterinary Microbiology and Journal of Virology as well as featured by news outlets around the globe. He received his Master’s and doctorate degrees from Pennsylvania State University in Biophysics and Molecular Cell Biology, respectively. Kousoulas received postdoctoral training under Dr. Bernard Roizman at the University of Chicago and with Dr. Lenore Pereira at the University of California at San Francisco.